|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Mao C, Domenico DR, Kim K, Hanson DJ and
Howard JM: Observations on the developmental patterns and the
consequences of pancreatic exocrine adenocarcinoma. Findings of 154
autopsies. Arch Surg. 130:125–134. 1995. View Article : Google Scholar
|
|
3
|
Vogel I, Krüger U, Marxsen J, et al:
Disseminated tumor cells in pancreatic cancer patients detected by
immunocytology: a new prognostic factor. Clin Cancer Res.
5:593–599. 1999.
|
|
4
|
Winter JM, Ting AH, Vilardell F, et al:
Absence of E-cadherin expression distinguishes noncohesive from
cohesive pancreatic cancer. Clin Cancer Res. 14:412–418. 2008.
View Article : Google Scholar
|
|
5
|
Iovanna J, Mallmann MC, Gonçalves A,
Turrini O and Dagorn JC: Current knowledge on pancreatic cancer.
Front Oncol. 2:62012. View Article : Google Scholar
|
|
6
|
Asuthkar S, Rao JS and Gondi CS: Drugs in
preclinical and early-stage clinical development for pancreatic
cancer. Expert Opin Investig Drugs. 21:143–152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Insulin-like growth factor-I
receptor in proliferation and motility of pancreatic cancer. World
J Gastroenterol. 16:1854–1858. 2010. View Article : Google Scholar
|
|
8
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Insulin-like growth factor I
receptor involvement in proliferation of NOR-P1 cells in serum-free
media. J Cell Biochem. 113:2714–2720. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rajpathak SN, Gunter MJ, Wylie-Rosett J,
et al: The role of insulin-like growth factor-I and its binding
proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab
Res Rev. 25:3–12. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katoh M and Katoh M: WNT signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen HJ, Hsu LS, Shia YT, Lin MW and Lin
CM: The β-catenin/TCF complex as a novel target of resveratrol in
the Wnt/β-catenin signaling pathway. Biochem Pharmacol.
84:1143–1153. 2012.
|
|
12
|
Wang HY, Liu T and Malbon CC:
Structure-function analysis of Frizzleds. Cell Signal. 18:934–941.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kirikoshi H, Sekihara H and Katoh M:
Expression profiles of 10 members of Frizzled gene family in human
gastric cancer. Int J Oncol. 19:767–771. 2001.PubMed/NCBI
|
|
14
|
Fujimoto T, Tomizawa M and Yokosuka O:
SiRNA of frizzled-9 suppresses proliferation and motility of
hepatoma cells. Int J Oncol. 35:861–866. 2009.PubMed/NCBI
|
|
15
|
Sagara N, Toda G, Hirai M, Terada M and
Katoh M: Molecular cloning, differential expression, and
chromosomal localization of human frizzled-1, frizzled-2, and
frizzled-7. Biochem Biophys Res Commun. 252:117–122. 1998.
View Article : Google Scholar
|
|
16
|
Zeng G, Germinaro M, Micsenyi A, et al:
Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma.
Neoplasia. 8:279–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jones S, Zhang X, Parsons DW, et al: Core
signaling pathways in human pancreatic cancers revealed by global
genomic analyses. Science. 321:1801–1806. 2008. View Article : Google Scholar
|
|
18
|
White BD, Chien AJ and Dawson DW:
Dysregulation of Wnt/β-catenin signaling in gastrointestinal
cancers. Gastroenterology. 142:219–232. 2012.
|
|
19
|
Pujal J, Capellá G and Real FX: The Wnt
pathway is active in a small subset of pancreas cancer cell lines.
Biochim Biophys Acta. 1762:73–79. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo Y, Qiu Z, Tian L, et al:
Identification of novel predictive markers for the prognosis of
pancreatic ductal adenocarcinoma. Hum Pathol. 44:69–76. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang JC, Thiere M, Henne-Bruns D,
Knippschild U and Kornmann M: Inhibition of pancreatic cancer cell
growth in vivo using a tetracycline-inducible cyclin D1 antisense
expression system. Pancreas. 42:141–148. 2012. View Article : Google Scholar
|
|
22
|
Heidegger I, Pircher A, Klocker H and
Massoner P: Targeting the insulin-like growth factor network in
cancer therapy. Cancer Biol Ther. 11:701–707. 2011. View Article : Google Scholar : PubMed/NCBI
|
